Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

Quantzig Conducted a Budget Impact Optimization for a Pharma Manufacturer to Identify the Best Vaccination Strategy

Posted on: 30 Aug 17

A leading pharma manufacturer in Europe approached Quantzig for assistance in evaluating the best vaccination strategy that is available in the manufacturing landscape. Quantzig assessed the budget impact of vaccinations using different vaccines. Since the incidence of vaccination in the market is increasing, the client wanted to quantify the health and budget impact of various vaccination strategies for pneumonia in adults and identify the most cost-effective method of treatment.

This Smart News Release features multimedia. View the full release here:

A leading pharma manufacturer in Europe wanted to assess the budget impact of vaccinations using different vaccines. (Graphic: Business Wire)

The recent financial pressure is influencing key players in the health care industry to better understand the value of their products by carrying out budget impact analysis. Such engagements allow organizations to determine the financial impact of the newly released products. Such services also assist in measuring a product’s affordability, understanding trade-offs for new products, and help in budget planning and forecasting.

According to Quantzig’s budget impact optimization experts, “The recent financial pressure on the health care industry has influenced the manufacturers to conduct robust budget impact analysis.”

Request a Free Demo to see how Quantzig’s solutions can help you

This budget impact optimization provided benefits that helped the client to:

  • Show that vaccination with Type 2 is less favorable as compared to vaccination with Type 1 based on demographic and clinical characteristics
  • Show that the vaccination with Type 2 is associated with higher costs as compared to the counterparts
  • Carry out a detailed sensitivity analysis for all scenarios with variations in the price of vaccines and other risk factors
  • Prove that the use of Type 1 and Type 2 vaccinations in combination was better than Type 2 alone; and had a reduced budget impact

This budget impact optimization offered predictive insights such as:

  • Creating an interactive dashboard to visualize patient engagement rates
  • Covering different patient profiles based on demography, vaccine administered and the costs incurred
  • Visualizing different scenarios and costs associated with the same for budget impact analysis and ease of comparison
  • Improving budget impact by 50%
  • Assessing health outcomes based on scenario analysis
  • Carrying out vaccination strategy based on the analysis of the population group

Request a Free Demo to see how Quantzig’s solutions can help you

View the inventory optimization study:

About Quantzig

Quantzig is a global analytics and advisory firm with offices in the US, UK, Canada, China, and India. For more than 12 years, we have assisted our clients across the globe with end-to-end data modeling capabilities to leverage analytics for prudent decision making. Today, our firm consists of 120+ clients, including 45 Fortune 500 companies. For more information on all of Quantzig’s services and the solutions they have provided to Fortune 500 clients across all industries, please contact us.

View source version on

Business Wire

Last updated on: 30/08/2017

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.